Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2013
Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical OncologyJyoti D Patel, Lada Krilov, Sylvia Adams, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2011
Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical OncologyNicholas J Vogelzang, Steven I Benowitz, Sylvia Adams, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2018
Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized TrialDavid Cella, Bernard Escudier, Nizar M Tannir, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 21, 2022
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216)Neeraj Agarwal, Catherine M Tangen, Maha H A Hussain, et al.The Journal of Urology|April 18, 2007
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot studyAdam S Kibel, Eli Rosenbaum, Michael W Kattan, et al.Clinical and Translational Radiation Oncology|January 19, 2019
A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer DatabaseBenjamin W Fischer-Valuck, Jeff M Michalski, Jessika A Contreras, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2023
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)Michael J Morris, Glenn Heller, David W Hillman, et al.Clinical Genitourinary Cancer|November 14, 2020
Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent ChemoradiotherapyBenjamin W Fischer-Valuck, Jeff M Michalski, Joanna G Harton, et al.The Lancet. Oncology|June 10, 2016
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trialToni K Choueiri, Bernard Escudier, Thomas Powles, et al.Cancer Medicine|May 24, 2019
Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancerBenjamin W Fischer-Valuck, Jeff M Michalski, Nandita Mitra, et al.Pageof 4